On a roll…

The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.

Lab co-author: Katie Lindblad

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.

Lab first author:  Hong Yuen 

Lab co-authors: Katie Lindblad, Sheenu, Greg, Meg, Matt, Nestor, Jingrong, Julie, Blair, Laura and Katie Lai.

MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.

Lab Co-authors:  Hong Yuen, Jingrong, Matt.

Refining AML outcome prediction.


With more to come soon….

Four generations of Hourigan Lab postbacs!

27th July 2018

An unexpected pleasure of the lab leaving party was having four generations of lab postbacs all in one place!

In order, from left to right:

Jack Ghannam 2018-Present

Katie Lindblad 2016-2018  (now PhD student, Mt. Sinai)

Matt Mulé 2014-2016  (now MD-PhD student, UNC and OxCam)

Meg Goswami 2012-2014  (now PhD student, GW-NIH)

This slideshow requires JavaScript.